PartsTable
Technical Data Sheet
Download PDF

1596335 — MIDAZOLAM INJECTION

✓ Government record, cited
— · COMPONENT
PRODUCT OVERVIEW

1596335: MIDAZOLAM INJECTION.

The MIDAZOLAM INJECTION is a the manufacturer industrial component. Key specifications include administration: INTRAMUSCULAR AND INTRAVENOUS, primary_container_type: VIAL, SINGLE DOSE, secondary_container_type: PACKAGE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 10, primary_container_content_quantity: 5.0 MILLIGRAMS. This part is cataloged in the U.S.

Government catalog under NSN 6505-01-695-1375, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.

Verify compatibility with your specific system configuration before ordering.

WHERE IT FITS
1596335
NSN: 6505-01-695-1375
FSC: 6505 — Drugs and Biologicals
CAGE: 89875 — DEFENSE LOGISTICS AGENCY DIRECTORATE OF MEDICAL MATERIEL DEFENSE SUPPLY CENTER PHILADELPHIA (USA)
SPECIFICATIONS
administrationINTRAMUSCULAR AND INTRAVENOUS
primary_container_typeVIAL, SINGLE DOSE
secondary_container_typePACKAGE
medical_designation_and_gradeUNITED STATES PHARMACOPEIA
total_primary_container_quantity10
primary_container_content_quantity5.0 MILLIGRAMS
controlled_substance_classificationSCHEDULE IV
part_name_assigned_by_controlling_agencyMIDAZOLAM INJECTION, USP 5 MG/5 ML VIAL 10S
NSN6505-01-695-1375
COMPONENT DIAGRAM
COMPONENT MAIN IC EDGE CONNECTOR No detailed specs available MIDAZOLAM INJECTION TITLE COMPONENT PN 1596335 MFR MIDAZOLAM INJECTION
KEY FEATURES
•
CONTROLLED SUBSTANCE CLASSIFICATION: SCHEDULE IV
•
ADMINISTRATION: INTRAMUSCULAR AND INTRAVENOUS
•
PRIMARY CONTAINER CONTENT QUANTITY: 5.0 MILLIGRAMS
•
SECONDARY CONTAINER TYPE: PACKAGE
•
MEDICAL DESIGNATION AND GRADE: UNITED STATES PHARMACOPEIA
•
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
TECHNICAL CHARACTERISTICS
CONTROLLED SUBSTANCE CLASSIFICATIONSCHEDULE IV
ADMINISTRATIONINTRAMUSCULAR AND INTRAVENOUS
PRIMARY CONTAINER CONTENT QUANTITY5.0 MILLIGRAMS
SECONDARY CONTAINER TYPEPACKAGE
MEDICAL DESIGNATION AND GRADEUNITED STATES PHARMACOPEIA
PRIMARY CONTAINER TYPEVIAL, SINGLE DOSE
SPECIAL FEATURES5 MG/5 ML (1 MG/ML)MIDAZOLAM (AS THE HYDROCHLORIDE) 10 X 5 ML VIALS; FOR IM OR IV USE ONLY. CONTAINS BENZYL ALCOHOL. STORE AT 20 -25 C (68 -77 F), EXCURSIONS PERMITTED TO 15 -30 C (59 -86 F) (SEE USP CONTROLLED ROOM TEMPERATURE).
PART NAME ASSIGNED BY CONTROLLING AGENCYMIDAZOLAM INJECTION, USP 5 MG/5 ML VIAL 10S
TOTAL PRIMARY CONTAINER QUANTITY10
OTHER ITEMS IN FSC 6505 — Drugs and Biologicals
Items in the same Federal Supply class. No interchangeability or substitution relationship is implied.
6505-00-000-0073 6505-00-000-0110 6505-00-000-0134 6505-00-000-0135 6505-00-001-3344 6505-00-001-3345 6505-00-001-3346 6505-00-001-3347
SUBSTITUTES & CROSS-REFERENCES 1
6505NCM217123Reference document
Same NSN cross-reference
Reference document — Secondary reference
LIFECYCLE
NSN statusActive· U.S. Government catalog
Shelf-life managedNo demilitarization required
Ready to buy 1596335?
Compare prices from verified sellers on eBay
Buy on eBay →
As an eBay Partner, PartsTable may earn a commission. Your price is not affected.
FREQUENTLY ASKED QUESTIONS
What is 1596335?
1596335 is a MIDAZOLAM INJECTION.
What parts can replace 1596335?
There is 1 known substitute for 1596335: 6505NCM217123. Substitute compatibility should be verified for your specific system.
What is the NSN for 1596335?
1596335 is cataloged in the U.S. Government catalog under NSN 6505-01-695-1375. This indicates validated use in U.S. government and defense supply chains.
Community Feedback
Leave a Comment
Comments are reviewed before appearing. You will receive an email to verify before your comment appears.

Request a Quote — 1596335